Model Pathways | Effect size | Boot SE | Boot CI |
---|
Lower | Upper |
---|
Direct effect | 0.1886 | 0.1358 | -0.0797 | 0.4528 |
Total indirect effect | 0.1403 | 0.0750 | 0.0354 | 0.3272 |
Indirect 1 | 0.0071 | 0.0322 | -0.0576 | 0.0759 |
Indirect 2 | 0.1121 | 0.0666 | 0.0177 | 0.2765 |
Indirect 3 | 0.0211 | 0.0150 | 0.0032 | 0.0614 |
- Adjusted for age, sex, disease duration, immunosuppressant, glucocorticoid, neutrophil, lymphocyte, monocyte, A/G, GLU, LDLc, HDLc
- Note. SMD in per 5-HU reduction. Indirect effect 1: SMD–TyG index–hypertension; Indirect effect 1: SMD–eGFR–hypertension; Indirect effect 1: SMD–TyG index–eGFR–hypertension
- Abbreviation: SLE, systemic lupus erythematosus; SMD, skeletal muscle radiodensity; eGFR, estimated glomerular filtration rate; TyG index, triglyceride-glucose index; A/G, albumin-globulin ratio; GLU, blood glucose; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol